| Product Information |
DR-XY47942_PI_01.pdf
|
| Registration Number |
DR-XY47942
|
| Generic Name |
Daclatasvir (as dihydrochloride)
|
| Brand Name |
Virdac 30
|
| Dosage Strength |
30 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antiviral
|
| Packaging |
White opaque HDPE bottle with white opaque child
resistant PP cap containing 28 tablets (Box of 28 tablets)
|
| Manufacturer |
Hetero Labs Limited (Unit V)
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Camber Pharmaceuticals, Inc.
|
| Distributor |
Camber Pharmaceuticals, Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
18 April 2022
|
| Expiry Date |
18 April 2027
|